{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:38:04Z","timestamp":1761561484450,"version":"3.38.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T00:00:00Z","timestamp":1289520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T00:00:00Z","timestamp":1289520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00535-010-0325-2","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T05:18:34Z","timestamp":1289452714000},"page":"17-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A 50-year experience with autoimmune hepatitis: and where are we now?"],"prefix":"10.1007","volume":"46","author":[{"given":"Ian R.","family":"Mackay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,12]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.3748\/wjg.14.3292","volume":"14","author":"IR Mackay","year":"2008","unstructured":"Mackay IR. Historical reflections on autoimmune hepatitis. World J Gastroenterol. 2008;14:3292\u2013300.","journal-title":"World J Gastroenterol"},{"key":"325_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5694\/j.1326-5377.1948.tb97104.x","volume":"1","author":"IJ Wood","year":"1948","unstructured":"Wood IJ, King WE, Parsons PJ, Perry JW, Freeman M, Lim-Brick L. Non-suppurative hepatitis: a study of acute and chronic forms with special reference to biochemical and histological changes. Med J Aust. 1948;1:249\u201361.","journal-title":"Med J Aust"},{"key":"325_CR3","first-page":"158","volume-title":"Lectures on the liver and its diseases","author":"HP Himsworth","year":"1947","unstructured":"Himsworth HP. Lectures on the liver and its diseases. Oxford: Blackwell; 1947. p. 158\u201361."},{"key":"325_CR4","first-page":"67","volume":"19","author":"KG Stern","year":"1946","unstructured":"Stern KG, Reiner M. Electrophoresis in medicine. Yale J Biol Med. 1946;19:67\u201399.","journal-title":"Yale J Biol Med"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJM195102152440702","volume":"244","author":"HJ Zimmerman","year":"1951","unstructured":"Zimmerman HJ, Heller P, Hill RP. Extreme hyperglobulinemia in subacute hepatic necrosis. N Engl J Med. 1951;244:245\u20139.","journal-title":"N Engl J Med"},{"key":"325_CR6","first-page":"654","volume":"30","author":"HG Kunkel","year":"1951","unstructured":"Kunkel HG, Ahrens EH, Eisenmenger WJ, Bongiovanni AM, Slater RJ. Extreme hypergammaglobulinemia in young women with liver disease. J Clin Invest. 1951;30:654.","journal-title":"J Clin Invest"},{"key":"325_CR7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0025-7125(16)35895-3","volume":"39","author":"JM Neefe","year":"1946","unstructured":"Neefe JM. Recent advances in the knowledge of \u2018virus hepatitis\u2019. Med Clin North Am. 1946;39:1407\u201343.","journal-title":"Med Clin North Am"},{"key":"325_CR8","first-page":"680","volume":"11","author":"RB Capps","year":"1948","unstructured":"Capps RB. Clinical aspects of the sequelae of acute hepatitis. Gastroenterology. 1948;11:680\u20134.","journal-title":"Gastroenterology"},{"key":"325_CR9","first-page":"288","volume":"99","author":"AR Page","year":"1960","unstructured":"Page AR, Good RA. Plasma cell hepatitis with special attention to steroid therapy. J Dis Child. 1960;99:288\u2013314.","journal-title":"J Dis Child"},{"key":"325_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imj.1953.2.2.113","volume":"2","author":"EG Saint","year":"1953","unstructured":"Saint EG, King WE, Joske RA, Finckh ES. The course of infectious hepatitis with special reference to prognosis and the chronic stage. Australas Ann Med. 1953;2:113\u201327.","journal-title":"Australas Ann Med"},{"key":"325_CR11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(55)93331-6","volume":"ii","author":"RA Joske","year":"1955","unstructured":"Joske RA, King WE. The \u201cL.E. Cell\u201d phenomenon in active chronic viral hepatitis. Lancet. 1955;ii:477\u201380.","journal-title":"Lancet"},{"key":"325_CR12","first-page":"25","volume":"23","author":"MM Hargraves","year":"1948","unstructured":"Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements: the \u201ctart\u201d cell and the \u201cL.E\u201d. cell. Proc Staff Meet Mayo Clin. 1948;23:25\u20138.","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/00000441-195006000-00010","volume":"20","author":"JR Haserick","year":"1950","unstructured":"Haserick JR, Lewis L, Bortz DW. Blood factor in acute disseminated lupus erythematosus: 1. Determination of gamma globulin as specific plasma fraction. Am J Med Sci. 1950;20:660\u20134.","journal-title":"Am J Med Sci"},{"key":"325_CR14","first-page":"1323","volume":"ii","author":"IR Mackay","year":"1956","unstructured":"Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet. 1956;ii:1323\u20136.","journal-title":"Lupoid hepatitis. Lancet"},{"key":"325_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0016-5085(61)80029-2","volume":"40","author":"IR Mackay","year":"1961","unstructured":"Mackay IR. The problem of persisting destructive disease of the liver. Gastroenterology. 1961;40:617\u201326.","journal-title":"Gastroenterology"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/hep.510380643","volume":"38","author":"A Reuben","year":"2003","unstructured":"Reuben A. A sheep in wolf\u2019s clothing. Hepatology. 2003;38:1596\u2013601.","journal-title":"Hepatology"},{"key":"325_CR17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archinte.1958.00260130044004","volume":"101","author":"IR Mackay","year":"1958","unstructured":"Mackay IR, Gajdusek DC. An autoimmune reaction against human tissue antigens in certain acute and chronic diseases: II. Clinical correlation. Arch Intern Med. 1958;101:30\u201346.","journal-title":"Arch Intern Med"},{"key":"325_CR18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.1.5331.656","volume":"i","author":"EJ Holbrow","year":"1963","unstructured":"Holbrow EJ, Asherson GL, Johnson GD, Barnes RDS, Carmichael PS. Antinuclear factor and other antibodies in blood and liver diseases. Br Med J. 1963;i:656\u20138.","journal-title":"Br Med J"},{"key":"325_CR19","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1749-6632.1965.tb19000.x","volume":"24","author":"IR Mackay","year":"1965","unstructured":"Mackay IR, Weiden S, Hasker J. Autoimmune hepatitis. Ann N Y Acad Sci. 1965;24:767\u201380.","journal-title":"Ann N Y Acad Sci"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.1840180435","volume":"18","author":"PJ Johnson","year":"1993","unstructured":"Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993;18:998\u20131005.","journal-title":"Hepatology"},{"key":"325_CR21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0016-5085(19)33286-X","volume":"63","author":"RD Soloway","year":"1972","unstructured":"Soloway RD, Summerskill DM, Baggenstoss AH, Shoenfield LJ. \u2018Lupoid\u2019 hepatitis, a non-entity in the spectrum of chronic active liver disease. Gastroenterology. 1972;63:458\u201365.","journal-title":"Gastroenterology"},{"key":"325_CR22","doi-asserted-by":"crossref","unstructured":"Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet. 1959;i 65\u20139.","DOI":"10.1016\/S0140-6736(59)91136-5"},{"key":"325_CR23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(65)92505-5","volume":"ii","author":"GD Johnson","year":"1965","unstructured":"Johnson GD, Holborow EJ, Glynn LE. Antibody to smooth muscle in patients with liver disease. Lancet. 1965;ii:878\u20139.","journal-title":"Lancet"},{"key":"325_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0016-5085(19)34365-3","volume":"51","author":"S Whittingham","year":"1966","unstructured":"Whittingham S, Irwin J, Mackay IR, Smalley M. Smooth muscle autoantibody in \u2018autoimmune\u2019 hepatitis. Gastroenterology. 1966;51:499\u2013505.","journal-title":"Gastroenterology"},{"key":"325_CR25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(66)92131-3","volume":"i","author":"S Whittingham","year":"1966","unstructured":"Whittingham S, Mackay IR, Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet. 1966;i:1333\u20135.","journal-title":"Lancet"},{"key":"325_CR26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0140-6736(66)92719-X","volume":"ii","author":"GD Johnson","year":"1966","unstructured":"Johnson GD, Holborow EJ, Glynn LE. Antibody to liver in lupoid hepatitis. Lancet. 1966;ii:416\u20138.","journal-title":"Lancet"},{"key":"325_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/jcp.29.5.403","volume":"29","author":"GF Bottazzo","year":"1976","unstructured":"Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976;29:403\u201310.","journal-title":"J Clin Pathol"},{"key":"325_CR28","first-page":"473","volume":"72","author":"G Gabbiani","year":"1973","unstructured":"Gabbiani G, Ryan GB, Lamelin J-P, Vassalli P, Majno G, Bouvier CA, et al. Human smooth muscle autoantibody\u2014identification as anti-actin antibody and a study of its binding to \u2018nonmuscular\u2019 cells. Am J Pathol. 1973;72:473\u201388.","journal-title":"Am J Pathol"},{"key":"325_CR29","first-page":"266","volume":"24","author":"K Lidman","year":"1976","unstructured":"Lidman K, Biberfeld G, Fagraeus A, Norberg R, Torstensson R, Utter G, et al. Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol. 1976;24:266\u201372.","journal-title":"Clin Exp Immunol"},{"key":"325_CR30","first-page":"621","volume":"38","author":"BH Toh","year":"1979","unstructured":"Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol. 1979;38:621\u20138.","journal-title":"Clin Exp Immunol"},{"key":"325_CR31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/00313025.2010.493867","volume":"42","author":"B-H Toh","year":"2010","unstructured":"Toh B-H, Taylor R, Pollock W, Dearden S, Gill C, Buchner C, Burlingame R. F-actin cell line but not ELISA discriminates \u201cactin-reactive\u201d from \u201cnon-actin-reactive\u201d smooth muscle antibody. Pathology. 2010;42:463\u20139.","journal-title":"Pathology"},{"key":"325_CR32","first-page":"331","volume":"15","author":"M Rizzetto","year":"1973","unstructured":"Rizzetto M, Swana G, Doniach D. Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973;15:331\u201344.","journal-title":"Clin Exp Immunol"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1084\/jem.161.5.1231","volume":"161","author":"F Alvarez","year":"1985","unstructured":"Alvarez F, Bernard O, Homberg JC, Kreibich G. Anti liver kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med. 1985;161:1231\u20136.","journal-title":"J Exp Med"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.1840070626","volume":"7","author":"J-C Homberg","year":"1987","unstructured":"Homberg J-C, Abuaf N, Bernard O, Alvarez F, Khalil SH, Poupon R, et al. Chronic active hepatitis with antiliver\/kidney microsome antibody type 1: a second type of autoimmune hepatitis. Hepatology. 1987;7:1333\u20139.","journal-title":"Hepatology"},{"key":"325_CR35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI113949","volume":"83","author":"MP Manns","year":"1989","unstructured":"Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullvan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db. J Clin Invest. 1989;83:1066\u201372.","journal-title":"J Clin Invest"},{"key":"325_CR36","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","volume":"130","author":"Y Ma","year":"2006","unstructured":"Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, et al. Polyclonal T cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology. 2006;130:868\u201382.","journal-title":"Gastroenterology"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.20109","volume":"39","author":"P Lapierre","year":"2004","unstructured":"Lapierre P, Djilali-saiah I, Vitozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology. 2004;39:1066\u201374.","journal-title":"Hepatology"},{"key":"325_CR38","doi-asserted-by":"crossref","unstructured":"Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol. 32 Suppl 1:181\u201397.","DOI":"10.1016\/S0168-8278(00)80425-0"},{"key":"325_CR39","first-page":"230","volume":"34","author":"T Kevenbeck","year":"2001","unstructured":"Kevenbeck T, Lohse AW, Gr\u00f6tzinger JA. A conformational approach suggests the function of the autoimmune hepatitis target antigen soluble liver antigen\/liver pancreas. Hepatology. 2001;34:230\u20133.","journal-title":"Hepatology"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/hep.1840080632","volume":"18","author":"E Martin","year":"1988","unstructured":"Martin E, Abauf N, Cavalli F, Durand V, Johanet C, Homberg J,-C. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988;18:1662\u20136.","journal-title":"Hepatology"},{"key":"325_CR41","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/eji.200323857","volume":"33","author":"P Lapierre","year":"2003","unstructured":"Lapierre P, Johanet C, Alvarez F. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis. Eur J Immunol. 2003;33:1869\u201378.","journal-title":"Eur J Immunol"},{"key":"325_CR42","doi-asserted-by":"crossref","first-page":"672","DOI":"10.5694\/j.1326-5377.1957.tb59755.x","volume":"i","author":"PM Last","year":"1957","unstructured":"Last PM. The treatment of active chronic infectious hepatitis with ACTH (corticotrophin) and cortisone. Med J Aust. 1957;i:672\u20136.","journal-title":"Med J Aust"},{"key":"325_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0002-9343(56)90003-1","volume":"21","author":"AG Bearn","year":"1956","unstructured":"Bearn AG, Kunkel HG, Slater RJ. The problem of chronic liver disease in young women. Am J Med. 1956;21:3\u201315.","journal-title":"Am J Med"},{"key":"325_CR44","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(58)92109-3","volume":"i","author":"EN O\u2019Brien","year":"1958","unstructured":"O\u2019Brien EN, Goble AJ, Mackay IR. Plasma-transaminase activity as an index of the effectiveness of cortisone in chronic hepatitis. Lancet. 1958;i:1245\u20139.","journal-title":"Lancet"},{"key":"325_CR45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(64)91627-7","volume":"i","author":"IR Mackay","year":"1964","unstructured":"Mackay IR, Weiden S, Ungar B. The treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine. Lancet. 1964;i:899\u2013902.","journal-title":"Lancet"},{"key":"325_CR46","first-page":"379","volume":"37","author":"IR Mackay","year":"1968","unstructured":"Mackay IR. Chronic hepatitis: effect of prolonged suppressive treatment and comparison of azathioprine with prednisolone. Q J Med. 1968;37:379\u201392.","journal-title":"Q J Med"},{"key":"325_CR47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","volume":"40","author":"GC Cook","year":"1971","unstructured":"Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971;40:159\u201385.","journal-title":"Q J Med"},{"key":"325_CR48","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.1840040409","volume":"4","author":"AJ Czaja","year":"1984","unstructured":"Czaja AJ, Davis GL, Ludwig J, Taswell HF. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis. Hepatology. 1984;4:622\u20137.","journal-title":"Hepatology"},{"key":"325_CR49","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0002-9343(58)90072-X","volume":"25","author":"G Klatskin","year":"1958","unstructured":"Klatskin G. Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus. Am J Med. 1958;25:333\u201358.","journal-title":"Am J Med"},{"key":"325_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/path.1711050103","volume":"105","author":"JFR Kerr","year":"1971","unstructured":"Kerr JFR. Shrinkage necrosis: a distinct mode of cellular death. J Pathol. 1971;105:13\u201320.","journal-title":"J Pathol"},{"key":"325_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1440-1746.1987.tb00152.x","volume":"2","author":"J Searle","year":"1987","unstructured":"Searle J, Harmon BV, Bishop CJ, Kerr JFR. Significance of single cell death by apoptosis in hepatobiliary disease. J Gastroenterol Hepatol. 1987;2:77\u201396.","journal-title":"J Gastroenterol Hepatol"},{"key":"325_CR52","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1749-6632.1965.tb19001.x","volume":"124","author":"H Popper","year":"1965","unstructured":"Popper H, Paronetto F, Schaffner F. Immune processes in the pathogenesis of liver disease. Ann N Y Acad Sci. 1965;124:781\u201399.","journal-title":"Ann N Y Acad Sci"},{"key":"325_CR53","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0140-6736(77)90845-5","volume":"310","author":"International Group of Pathologists","year":"1977","unstructured":"International Group of Pathologists. Acute and chronic hepatitis revisited. Lancet. 1977;310:914\u20139.","journal-title":"Lancet"},{"key":"325_CR54","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bmj.4.5891.517","volume":"iv","author":"S Whittingham","year":"1973","unstructured":"Whittingham S, Mackay IR, Thanabalasundrum RS, Chuttani HK, Manjuran R, Seah CS, et al. Chronic liver disease: differences in autoimmune serological reactions between Australians and Asians. Br Med J. 1973;iv:517\u20139.","journal-title":"Br Med J"},{"key":"325_CR55","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-66-5-924","volume":"66","author":"BS Blumberg","year":"1967","unstructured":"Blumberg BS, Gerstley DA, Hungerford DA, London WT, Sutnick AT. A serum antigen (Australia antigen) in Down\u2019s syndrome, leukemia, and hepatitis. Ann Intern Med. 1967;66:924\u201331.","journal-title":"Ann Intern Med"},{"key":"325_CR56","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1073\/pnas.60.3.814","volume":"60","author":"AM Prince","year":"1968","unstructured":"Prince AM. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci USA. 1968;60:814\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"325_CR57","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-77-4-649","volume":"77","author":"IR Mackay","year":"1972","unstructured":"Mackay IR. The prognoses of chronic hepatitis. Ann Intern Med. 1972;77:649\u201351.","journal-title":"Ann Intern Med"},{"key":"325_CR58","first-page":"527","volume":"48","author":"JS Pedersen","year":"1982","unstructured":"Pedersen JS, Toh BH, Mackay IR, Tait BD, Gust ID, Kastelan A, Hadzic N. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments, with two types of chronic active hepatitis. Clin Exp Immunol. 1982;48:527\u201332.","journal-title":"Clin Exp Immunol"},{"key":"325_CR59","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Burroughs AK, Cancado EL, Chapman RW, et al. International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929\u201338.","journal-title":"J Hepatol"},{"key":"325_CR60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/hep.22322","volume":"48","author":"EM Hennes","year":"2008","unstructured":"Hennes EM, Zeniya M, Czaja A, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169\u201376.","journal-title":"Hepatology"},{"key":"325_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, Cancado ELR, Mackay IR, Manns MP, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol. 2004;41:1\u20137.","journal-title":"J Hepatol"},{"key":"325_CR62","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/hep.22513","volume":"48","author":"A Czaja","year":"2008","unstructured":"Czaja A. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology. 2008;48:1540\u20138.","journal-title":"Hepatology"},{"key":"325_CR63","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","volume":"50","author":"AD Yeoman","year":"2009","unstructured":"Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease. Hepatology. 2009;50:538\u201345.","journal-title":"Hepatology"},{"key":"325_CR64","unstructured":"Zeniya M. Diagnostic criteria of AIH. Nihon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol). 2010;107 Suppl:A57."},{"key":"325_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jaut.2009.09.006","volume":"33","author":"IR Mackay","year":"2009","unstructured":"Mackay IR. Clustering and commonalities among autoimmune diseases. J Autoimmun. 2009;33:170\u20137.","journal-title":"J Autoimmun"},{"issue":"1980","key":"325_CR66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02054106","volume":"3","author":"KH Meyer zum B\u00fcschenfelde","year":"1980","unstructured":"Meyer zum B\u00fcschenfelde KH, H\u00fctteroth TH, Manns M, M\u00f6ller B. The role of liver membrane antigens as targets in autoimmune type liver disease. Springer Semin Immunopathol. 1980;3(1980):297\u2013315.","journal-title":"Springer Semin Immunopathol"},{"key":"325_CR67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0016-5085(80)90207-3","volume":"78","author":"FV Chisari","year":"1980","unstructured":"Chisari FV. Liver-specific protein in perspective. Gastroenterology. 1980;78:168\u201370.","journal-title":"Gastroenterology"},{"key":"325_CR68","first-page":"347","volume":"55","author":"IG McFarlane","year":"1984","unstructured":"McFarlane IG, McFarlane B, Major GN, Tolley P, Williams R. Identification of the hepatic-receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol. 1984;55:347\u201354.","journal-title":"Clin Exp Immunol"},{"key":"325_CR69","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0016-5085(94)90129-5","volume":"107","author":"U Treichel","year":"1994","unstructured":"Treichel U, McFarlane B, Seki T, Krawitt E, Alissi N, Stickel F, et al. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 1994;107:799\u2013804.","journal-title":"Gastroenterology"},{"key":"325_CR70","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/hep.22149","volume":"47","author":"F Tahiri","year":"2008","unstructured":"Tahiri F, Le Naour F, Huguet S, Lai-Kuen R, Didier S, Johanet C, et al. Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool. Hepatology. 2008;47:937\u201348.","journal-title":"Hepatology"},{"key":"325_CR71","first-page":"50","volume-title":"Actin, actin-binding proteins and disease","author":"IR Mackay","year":"2007","unstructured":"Mackay IR, Martinez-Neira R, Whittingham S, Nicolau D, Toh B-H. Autoantigenicity of actin. In: dos Remedios C, Chhabra D, editors. Actin, actin-binding proteins and disease. New York: Springer; 2007. p. 50\u201364."},{"key":"325_CR72","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(72)92149-6","volume":"ii","author":"IR Mackay","year":"1972","unstructured":"Mackay IR, Morris PJ. Association of autoimmune chronic hepatitis with HLA1,8. Lancet. 1972;ii:793\u20135.","journal-title":"Lancet"},{"key":"325_CR73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0016-5085(80)90080-3","volume":"79","author":"IR Mackay","year":"1980","unstructured":"Mackay IR, Tait BD. HLA associations with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology. 1980;79:95\u20138.","journal-title":"Gastroenterology"},{"key":"325_CR74","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","volume":"174","author":"AJ Czaja","year":"2000","unstructured":"Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000;174:250\u20139.","journal-title":"Immunol Rev"},{"key":"325_CR75","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/hep.1840130415","volume":"13","author":"PT Donaldson","year":"1991","unstructured":"Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 1991;13:701\u20136.","journal-title":"Hepatology"},{"key":"325_CR76","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/art.23377","volume":"58","author":"JH Reed","year":"2008","unstructured":"Reed JH, Jackson MW, Gordon TP. A B cell apotope of Ro 60 in systemic lupus erythematosus. Arthritis Rheum. 2008;58:1125\u20139.","journal-title":"Arthritis Rheum"},{"key":"325_CR77","first-page":"723","volume":"57","author":"JM Davies","year":"2000","unstructured":"Davies JM (Co-coordinator, Multiauthor Review). Molecular mimicry. Cell Mol Life Sci. 2000;57:723\u201358.","journal-title":"Cell Mol Life Sci"},{"key":"325_CR78","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(95)91438-2","volume":"346","author":"S Vento","year":"1995","unstructured":"Vento S, Guella L, Mirandola F, Cainelli F, Di Perri G, Solbiati M, et al. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet. 1995;346:608\u20139.","journal-title":"Lancet"},{"key":"325_CR79","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/B978-0-12-374994-9.10046-4","volume-title":"Systemic lupus erythematosus","author":"IR Mackay","year":"2011","unstructured":"Mackay IR. Gastrointestinal: liver. In: Lahita RG, editor. Systemic lupus erythematosus. 5th ed. London: Elsevier Academic; 2011. p. 865\u201386.","edition":"5"},{"key":"325_CR80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-3-642-61013-4_10","volume-title":"Handbook of experimental pharmacology series: drug-induced hepatotoxicity","author":"IR Mackay","year":"1996","unstructured":"Mackay IR. Immune mechanisms and liver toxicity. In: Cameron RG, Feuer G, de la Inglesia FA, editors. Handbook of experimental pharmacology series: drug-induced hepatotoxicity. Berlin: Springer; 1996. p. 221\u201347."},{"key":"325_CR81","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-2005-916330","volume":"25","author":"IR Mackay","year":"2005","unstructured":"Mackay IR. The etiopathogenesis of autoimmunity. Semin Liver Dis. 2005;25:239\u201350.","journal-title":"Semin Liver Dis"},{"key":"325_CR82","doi-asserted-by":"crossref","unstructured":"Biburger M, Tiegs G. Animal models of autoimmune liver disease. In: Gershwin ME, Vierling JM, Manns MP, editors. Liver immunology. Principles and practice. 2nd ed. Totowa NJ: Humana; 2007. p. 293\u2013308.","DOI":"10.1007\/978-1-59745-518-3_24"},{"key":"325_CR83","unstructured":"Watanabe N. Regulatory T cells and PD-1\u2014mediated signaling in AIH. Nihon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol). 2010;107 Suppl:A54."},{"key":"325_CR84","doi-asserted-by":"publisher","unstructured":"Lleo A, Shimoda S, Ishibashi H, Gershwin ME. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol. 2010. doi:10.1007\/s00535-010-0303-8.","DOI":"10.1007\/s00535-010-0303-8"},{"key":"325_CR85","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2460\/javma.1982.180.12.1438","volume":"180","author":"GF Johnson","year":"1982","unstructured":"Johnson GF, Zawie DA, Gilbertson SR, Sternlieb I. Chronic active hepatitis in Doberman pinschers. J Am Vet Med Assoc. 1982;180:1438\u201342.","journal-title":"J Am Vet Med Assoc"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-010-0325-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0325-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T19:04:35Z","timestamp":1740683075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-010-0325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,12]]},"references-count":85,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s00535-010-0325-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2010,11,12]]},"assertion":[{"value":"29 June 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}